Sexual Health-related Quality of Life in Women with Pulmonary Arterial Hypertension: Compensating for Loss.

Health-related quality of life in patients with pulmonary arterial hypertension (PAH) has become increasingly important in disease management as numerous treatment options have improved prognosis and time to clinical worsening. Sexual health-related quality of life (SHRQoL) is poorly understood in patients with PAH, but previous work has shown that patients may face unrecognized challenges, especially related to parenteral prostanoid analogue therapies. Using qualitative methods, to describe challenges and perspectives related to SHRQoL among women with PAH.

Insights from the Menstrual Cycle in Pulmonary Arterial Hypertension.

Sex hormones play a role in pulmonary arterial hypertension (PAH), but the menstrual cycle has never been studied. We conducted a prospective observational study of eight women with stable PAH and 20 healthy controls over one cycle. Participants completed four study visits 1 week apart starting on the first day of menstruation.

Sexual health and health-related quality of life among women with pulmonary arterial hypertension.

Pulmonary arterial hypertension (PAH) is characterized by progressive limitations in physical activity and health-related quality of life (HRQoL). HRQoL deficits may extend beyond the traditional domains of physical activity, psychological health, and emotional wellbeing to sexual health and function. Sexual HRQoL has not been studied in PAH, nor has the impact of PAH therapies themselves on sexual health and intimacy.